Cita APA (7a ed.)

Onishi, T., Maeda, R., Terada, M., Sato, S., Fujii, T., Ito, M., . . . Tanaka, M. (2021). A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice. Nature Portfolio.

Cita Chicago Style (17a ed.)

Onishi, Tomohiro, Ryouta Maeda, Michiko Terada, Sho Sato, Takahiro Fujii, Masahiro Ito, Kentaro Hashikami, Tomohiro Kawamoto, y Maiko Tanaka. A Novel Orally Active HDAC6 Inhibitor T-518 Shows a Therapeutic Potential for Alzheimer’s Disease and Tauopathy in Mice. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Onishi, Tomohiro, et al. A Novel Orally Active HDAC6 Inhibitor T-518 Shows a Therapeutic Potential for Alzheimer’s Disease and Tauopathy in Mice. Nature Portfolio, 2021.